Clinical experience with integrase inhibitors in HIV-2-infected individuals in Spain

Autor: Requena, S., Lozano, AB., Caballero, E., García, F., Nieto, MC., Téllez, R., Fernández, JM., Trigo, M., Rodríguez-Avial, I., Martín-Carbonero, L., Miralles, P., Soriano, V., de, Mendoza, C., HIV-2 Spanish Study Group, Rodríguez, C., Vera, M., Del, Romero, J., Marcaida, G., Ocete, MD., Aguilera, A., BENITO, R., de, Lejarazu, RO., Rojo, S., Eirós, JM., Ramos, C., García, J., Paz, I., Diz, J., García-Campello, M., Rodríguez-Iglesias, M., Hernández-Betancor, A., Martín, AM., Ramos, JM., Gimeno, A., Sánchez, V., Gómez-Hernando, C., Cilla, G., Pérez-Trallero, E., Fernández-Pereira, L., Niubó, J., Hernández, M., López-Lirola, AM., Gómez-Sirvent, JL., Force, L., Cabrera, J., Pérez, S., Morano, L., Raya, C., González-Praetorius, A., Cifuentes, C., Peñaranda, M., Montejo, JM., Roc, L., Viciana, I., Fernández-Fuertes, E., García-Bermejo, I., Gaspar, G., Górgolas, M., Pérez, L., Valeiro, M., Aldamiz, T., Margall, N., Suárez, A., Benítez-Gutiérrez, L., Cuervas-Mons, V., Barreiro, P.

Publikováno v: Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname

Background: HIV-2 is a neglected virus despite estimates of 1–2 million people being infected worldwide. The virus is naturally resistant to some antiretrovirals used to treat HIV-1 and therapeutic options are limited for patients with HIV-2. Metho

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::fcb8ee7aa43ba980dc8cf4a299da23ad
http://zaguan.unizar.es/record/87679

Clinical Presentation of Individuals With Human T-Cell Leukemia Virus Type-1 Infection in Spain

Autor: de Mendoza, C, Piron, M, Gonzalez, R, Jimenez, A, Caballero, E, Roc, L, Benito, R, Ramos, JM, Soriano, V, Rodriguez, C, Vera, M, del Romero, J, Marcaida, G, Ocete, MD, Molina, I, Aguilera, A, Rodriguez-Calvino, JJ, Navarro, D, Rivero, C, Vilarino, MD, Algarate, S, Gil, J, de Lejarazu, RO, Rojo, S, Eiros, JM, San Miguel, A, Manzardo, C, Miro, JM, Garcia, J, Paz, I, Poveda, E, Calderon, E, Escudero, D, Trigo, M, Diz, J, Garcia-Campello, M, Rodriguez-Iglesias, M, Hernandez-Betancor, A, Martin, AM, Gimeno, A, Gutierrez, F, Rodriguez, JC, Sanchez, V, Gomez-Hernando, C, Cilla, G, Perez-Trallero, E, Lopez-Aldeguer, J, Fernandez-Pereira, L, Niubo, J, Hernandez, M, Lopez-Lirola, AM, Gomez-Sirvent, JL, Force, L, Cifuentes, C, Perez, S, Morano, L, Raya, C, Gonzalez-Praetorius, A, Perez, JL, Penaranda, M, Hernaez-Crespo, S, Montejo, JM, Martinez-Sapina, A, Viciana, I, Cabezas, T, Lozano, A, Fernandez, JM, Garcia-Bermejo, I, Gaspar, G, Garcia, R, Gorgolas, M, Vegas, C, Blas, J, Miralles, P, Valeiro, M, Aldamiz, T, Margall, N, Guardia, C, do Pico, E, Polo, I, Aguinaga, A, Ezpeleta, C, Sauleda, S, Torres, P, Blanco, L, Suarez, A, Rodriguez-Avial, I, Perez-Rivilla, A, Parra, P, Fernandez, M, Fernandez-Alonso, M, Trevino, A, Requena, S, Benitez-Gutierrez, L, Cuervas-Mons, V, Barreiro, P, Corral, O, Gomez-Gallego, F

Publikováno v: Open Forum Infectious Diseases
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

Background. Although only 8%-10% of persons infected with human T-cell leukemia virus type 1 (HTLV-1) may develop virus-associated diseases lifelong, misdiagnosis of asymptomatic infected carriers frequently leads to late diagnoses. Methods. A nation

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::821409508f1eb10d0066bdefe659e38c
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=3002

HIV co-infection in HTLV-1 carriers in Spain

Autor: de Mendoza, C, Caballero, E, Aguilera, A, Benito, R, Macia, D, Garcia-Costa, J, Soriano, V, Rodriguez, C, Vera, M, del Romero, J, Marcaida, G, Ocete, MD, Molina, I, Rodriguez-Calvino, JJ, Navarro, D, Rivero, C, Vilarino, MD, Algarate, S, Gil, J, de Lejarazu, RO, Rojo, S, Eiros, JM, San Miguel, A, Manzardo, C, Mira, JM, Garcia, J, Paz, I, Poveda, E, Calderon, E, Escudero, D, Trigo, M, Diz, J, Garcia-Campello, M, Rodriguez-Iglesias, M, Hernandez-Betancor, A, Martin, AM, Ramos, JM, Gimeno, A, Gutierrez, F, Rodriguez, JC, Sanchez, V, Gomez-Hernando, C, Cilla, G, Perez-Trallero, E, Lopez-Aldeguer, J, Fernandez-Pereira, L, Niubo, J, Hernandez, M, Lopez-Lirola, AM, Gomez-Sirvent, JL, Force, L, Cifuentes, C, Raya, C, Gonzalez-Praetorius, A, Perez, JL, Penaranda, M, Hernaez-Crespo, S, Montejo, JM, Roc, L, Martinez-Sapina, A, Viciana, I, Cabezas, T, Lozano, A, Fernandez, JM, Garcia-Bermejo, I, Gaspar, G, Garcia, R, Gorgolas, M, Vegas, C, Blas, J, Miralles, P, Valeiro, M, Aldamiz, T, Margall, N, Guardia, C, do Pico, E, Polo, I, Aguinaga, A, Ezpeleta, C, Sauleda, S, Piron, M, Gonzalez, R, Barea, L, Jimenez, A, Blanco, L, Suarez, A, Rodriguez-Avial, I, Perez-Rivilla, A, Parra, P, Fernandez, M, Fernandez-Alonso, M, Reina, G, Trevino, A, Requena, S, Benitez-Gutierrez, L, Cuervas-Mons, V, Barreiro, P, Corral, O, Gomez-Gallego, F, Perez, S, Morano, L, Spanish HTLV Network

Publikováno v: VIRUS RESEARCH
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname

Background: Human retroviruses HIV and HTLV share transmission routes. HIV widely spread in Spain during the 80 s through injection drug use and sex, and nowadays HIV rates in Spain account for one of the largest in Europe. In contrast, HTLV-1 is not

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::ccb6216bd75c54598d1ae1b2dac04cde
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=10221

One-step diagnosis strategy together with multidisciplinary telematics referral perform an effective approach for identifying and treating patients with active Hepatitis C infection.

Autor: Torrecillas M; General University Hospital Consortium of Valencia, Department of Clinical Microbiology, Avenida Tres Cruces, 2. CP, 46014 Valencia, Spain., Gómez-Muñoz N; General University Hospital Consortium of Valencia, Department of Infectious Disease, Avenida Tres Cruces, 2. CP, 46014 Valencia, Spain., Ocete MD; General University Hospital Consortium of Valencia, Department of Clinical Microbiology, Avenida Tres Cruces, 2. CP, 46014 Valencia, Spain; School of Medicine, Catholic University of Valencia, Spain. Electronic address: ocete_mar@gva.es., Cuevas PR; General University Hospital Consortium of Valencia, Department of Infectious Disease, Avenida Tres Cruces, 2. CP, 46014 Valencia, Spain., Madrid MD; General University Hospital Consortium of Valencia, Department of Gastroenterology and Hepatology; School of Medicine, University of Valencia, Spain., González EO; General University Hospital Consortium of Valencia, Department of Infectious Disease, Avenida Tres Cruces, 2. CP, 46014 Valencia, Spain; School of Medicine, University of Valencia, Spain., Cardona CG; General University Hospital Consortium of Valencia, Department of Clinical Microbiology, Avenida Tres Cruces, 2. CP, 46014 Valencia, Spain; School of Medicine, University of Valencia, Spain., García-Deltoro M; General University Hospital Consortium of Valencia, Department of Infectious Disease, Avenida Tres Cruces, 2. CP, 46014 Valencia, Spain; School of Medicine, University of Valencia, Spain.

Publikováno v: Annals of hepatology [Ann Hepatol] 2022 Jan-Feb; Vol. 27 (1), pp. 100542. Date of Electronic Publication: 2021 Sep 24.

GEHEP 010 study: Prevalence and distribution of hepatitis B virus genotypes in Spain (2000-2016).

Autor: Aguilera A; Complexo Hospitalario Universitario de Santiago, Santiago de Compostela, Instituto de Investigación Sanitaria de Santiago IDIS, Spain., Trastoy R; Hospital Universitario Vall d'Hebrón, Barcelona, Spain., Rodríguez-Frias F; Hospital Universitario Vall d'Hebrón, Barcelona, Spain., Muñoz-Bellido JL; Complejo Asistencial Universitario de Salamanca, Salamanca, Spain., Melón S; Hospital Universitario Central de Asturias, Oviedo, Spain., Suárez A; Hospital Clínico Universitario San Carlos, Madrid, Spain., Orduña A; Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Viciana I; Hospital Universitario Virgen de la Victoria, Málaga, Spain., Bernal S; Hospital Universitario Virgen de Valme, Sevilla, Spain., García-Bujalance S; Hospital Universitario La Paz, Madrid, Spain., Montiel N; Hospital Costa del Sol, Marbella, Spain., Molina JM; Hospital Universitario La Fe, Valencia, Spain., Basaras M; Universidad del País Vasco, Bilbao, Spain., Fernández-Cuenca F; Hospital Universitario Virgen Macarena, Sevilla, Spain., García-Arata I; Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain., Reina G; Clínica Universitaria de Navarra, Pamplona, Spain., Ocete MD; Hospital Universitario General de Valencia, Valencia, Spain., Fuentes A; Hospital Universitario San Cecilio, Instituto de Investigación Biosanitaria Ibs, Av. de la Innovación S/N, 18016 Granada, Spain., Navarro-de la Cruz D; Hospital Universitario Vall d'Hebrón, Barcelona, Spain., Nieto L; Hospital Universitario Vall d'Hebrón, Barcelona, Spain., Blazquez de Castro A; Complejo Asistencial Universitario de Salamanca, Salamanca, Spain., Buti M; Hospital Universitario Vall d'Hebrón, Barcelona, Spain., Álvarez M; Hospital Universitario San Cecilio, Instituto de Investigación Biosanitaria Ibs, Av. de la Innovación S/N, 18016 Granada, Spain., García F; Hospital Universitario San Cecilio, Instituto de Investigación Biosanitaria Ibs, Av. de la Innovación S/N, 18016 Granada, Spain. Electronic address: fegarcia@ugr.es.

Publikováno v: The Journal of infection [J Infect] 2020 Oct; Vol. 81 (4), pp. 600-606. Date of Electronic Publication: 2020 Jul 22.